Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference - CNBC
Novo Nordisk's CEO spoke about GLP-1 pricing and Pfizer's CEO spoke about the company's obesity ambitions while at the JPMorgan Healthcare Conference....
LivestreamMenuMake ItselectUSAINTLLivestreamSearch quotes, news & videosLivestreamWatchlistSIGN INCreate free accountMarketsBusinessInvestingTechPoliticsVideoWatchlistInvesting ClubPROLivestreamMenu
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions.
Good morning from San Francisco! It's day three of the annual JPMorgan Healthcare Conference — the...
Where to Invest $1,000 Right Now
Our AI-powered stock prediction tool delivers actionable insights to help you make smarter investment decisions. With advanced analytics and market trends, discover the best opportunities today.
*EstimateMyStock analytics as of April 18, 2025
Key Takeaways
- Key insights unavailable.
- Check the full article.
- Explore related news.